Hotchkis & Wiley Capital Management
UTMD icon

Hotchkis & Wiley Capital Management’s Utah Medical Products UTMD Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.53M Sell
89,131
-19,870
-18% -$1.25M 0.02% 378
2025
Q4 		$6.1M Hold
109,001
– – 0.02% 373
2025
Q3 		$6.86M Sell
109,001
-2,949
-3% -$174K 0.02% 322
2025
Q2 		$6.37M Buy
111,950
+10,310
+10% +$561K 0.02% 359
2025
Q1 		$5.7M Buy
101,640
+26,460
+35% +$1.59M 0.02% 358
2024
Q4 		$4.62M Sell
75,180
-13,830
-16% -$894K 0.02% 397
2024
Q3 		$5.96M Buy
89,010
+50,030
+128% +$3.4M 0.02% 376
2024
Q2 		$2.6M Buy
38,980
+3,360
+9% +$229K 0.01% 462
2024
Q1 		$2.53M Buy
+35,620
New +$2.67M 0.01% 461

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return